Latest AI and machine learning research in skin cancer for healthcare professionals.
PD-L1 expression is used to determine oncology patients' response to and eligibility for immunologi...
Artificial Intelligence (AI) is a branch of computer science that deals with mathematical algorithms...
Cutaneous oncology is currently a rapidly evolving field. Dermoscopy, total body photography, biomar...
MOTIVATION: Tumor mutational burden (TMB) is an indicator of the efficacy and prognosis of immune ch...
Melanocytic lesions occur on the surface of the skin, in which the malignant type is melanoma with a...
Human leukocyte antigens (HLA) regulate various innate and adaptive immune responses and play a cruc...
Immunotherapy offers the potential for durable clinical benefit but calls into question the associat...
The recent, rapid advances in immuno-oncology have revolutionized cancer treatment and spurred furth...
Skin cancers occur commonly worldwide. The prognosis and disease burden are highly dependent on the ...
Cancer therapeutics cause various treatment-related changes that may impact patient follow-up and di...
The ability to identify antigenic determinants of pathogens, or epitopes, is fundamental to guide ra...
MicroRNAs constitute small non-coding RNAs that play a pivotal role in regulating the translation an...
The antibody drug field has continually sought improvements to methods for candidate discovery and e...
Skin cancer remains the most commonly diagnosed cancer in the USA with more than 1 million new cases...
The objective of this study was to compute threshold values for the diameter of superficial spreadin...
Advancements in dermoscopy techniques have elucidated identifiable characteristics of melanoma which...
Melanoma is considered as one of the world's deadly cancers. This type of skin cancer will spread to...
BACKGROUND: To assess the additive value of dual-energy CT (DECT) over single-energy CT (SECT) to ra...
A basket trial in oncology encompasses multiple "baskets" that simultaneously assess one treatment i...
Glioblastoma (GBM) is the most malignant and lethal intracranial tumor, with extremely limited treat...
General practitioners (GPs) are playing a key role in skin cancer screening. Non-melanoma skin cance...